Table: begin end state 1 29 cytoplasmic 30 52 transmembrane 53 64 non-cytoplasmic 65 84 transmembrane 85 94 cytoplasmic 95 114 transmembrane 115 120 non-cytoplasmic 121 142 transmembrane 143 152 cytoplasmic 153 174 transmembrane 175 180 non-cytoplasmic 181 204 transmembrane 205 253 cytoplasmic 254 282 transmembrane 283 300 non-cytoplasmic 301 321 transmembrane 322 328 cytoplasmic 329 346 transmembrane 347 351 non-cytoplasmic 352 370 transmembrane 371 389 cytoplasmic 390 414 transmembrane 415 420 non-cytoplasmic 421 442 transmembrane 443 448 cytoplasmic
Input: >Pf1N1B4_3231 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_3231 MNQPQSAVGNCLDVQSFINTQPISRYQWRVVILCFLIVFLDGLDTAAMGFIAPALSQDWG IDRASLGPVMSAALIGMVFGALGSGPLADRFGRKVVLVGAVLVFGAFSLASAYSTNVDQL LVLRFLTGLGLGAGMPNATTLLSEYTPERKKSLLVTSMFCGFNLGMAGGGFISAKLIPAF GWHSLLMIGGVLPLILAVVLLFWLPESARYLVVRNRGTDKVRKTLAPIDPAMVAQASSFS VPEQKTVKARNVFAVIFSGTYSTGTLLLWLTYFMGLVIVYLLTSWLPTLMRDSGASMEQA AFIGALFQFGGVLSAVGVGWAMDRFNPHKVIGIFYLFAGVFAYAVGQSLGSITLLATLVL VAGMCVNGAQSAMPSLAARFYPTQGRATGVSWMLGIGRFGAILGAWMGATLLGLGWNFEQ VLTALVIPAALATTAVVIKGMVSHADAT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server